Kidney research reveals a complex picture of life-saving treatments that show genuine promise but deliver frustratingly mixed ...

Millions of Americans have chronic kidney disease without knowing it - discover the warning signs and new treatments that ...

Employment rates for patients with end-stage kidney disease were higher for those with access to home hemodialysis or evening ...

Clinical trial evaluating changes in urine protein-to-creatinine ratio, a widely-accepted endpoint measuring risk reduction ...

If the treatment wins FDA approval, its success will depend on pricing. Vera's rival, Otsuka Pharmaceutical, which earned an ...

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

As many as nine million Britons may be unknowingly at heightened risk of heart attacks, strokes and kidney failure because ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

After two are hospitalized within weeks, doctor behind pioneering study on glyoxylic acid says straightening products still ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

FDA assigned PDUFA target action date of July 7, 2026.If approved, atacicept would be the first B cell modulator targeting ...